The reduced OCT4 and CD44 expression confirmed our findings that LDR is capable of diminishing CSC-like population in MDA-MB231 triple-negative breast cancer cells (Fig. 1D). This evidence concerns the gene CD44 and triple-negative breast carcinoma.